The US Food and Drug Administration (FDA) has approved a new plaque psoriasis drug.

Enbrel's new biosimilar recently got the green light it needed to treat several inflammatory health conditions.

The US Food and Drug Administration (FDA) recently approved a new treatment option for adults with moderate to severe plaque psoriasis.

As a new year begins, we celebrate the beginning of something new and exciting. This year, that includes several new medication approvals from the US Food and Drug Administration (FDA).

The US Food and Drug Administration (FDA) has approved a new medication to treat multiple chronic inflammatory diseases.

The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system.

The US Food and Drug Administration has approved a new medication to treat psoriasis, a skin condition marked by red patches and flaking, silvery scales.

The first-ever medication to treat plaque psoriasis in children has been approved.

The US Food and Drug Administration has approved its fourth biosimilar.

The US Food and Drug Administration (FDA) has approved the first biosimilar etanercept.